Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Focal ischemic damage is reduced by CPP-ene studies in two animal models.

R Bullock1, J McCulloch, D I Graham

  • 1Department of Neurosurgery, University of Glasgow, Scotland.

Stroke
|November 1, 1990
PubMed
Summary

D-CPP-ene, a novel N-methyl-D-aspartate antagonist, significantly reduced brain damage in animal models of stroke and traumatic brain injury. This compound shows promise for treating ischemic conditions and intracranial hematomas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The neuroinflammatory response in humans after traumatic brain injury.

Neuropathology and applied neurobiology·2012
Same author

Reproducible peracute glutamate-induced focal lesions of the normal rat brain using microdialysis.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2008
Same author

No evidence for the presence of apolipoprotein epsilon4, interleukin-lalpha allele 2 and interleukin-1beta allele 2 cause an increase in programmed cell death following traumatic brain injury in humans.

Clinical neuropathology·2006
Same author

Association of APOE e4 and cerebrovascular pathology in traumatic brain injury.

Journal of neurology, neurosurgery, and psychiatry·2006
Same author

Neuropathology of the vegetative state after head injury.

Neuropsychological rehabilitation·2005
Same author

Experimental models of traumatic brain injury: do we really need to build a better mousetrap?

Neuroscience·2005

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Focal cerebral ischemia and traumatic intracranial hematomas cause significant neuronal damage.
  • N-methyl-D-aspartate (NMDA) receptors play a critical role in excitotoxicity following ischemic events.
  • Developing effective neuroprotective agents is crucial for managing these neurological conditions.

Purpose of the Study:

  • To evaluate the neuroprotective effects of a novel competitive NMDA antagonist, D-CPP-ene (SDZ-EAA 494).
  • To assess D-CPP-ene's efficacy in established animal models of focal cerebral ischemia and subdural hematoma.

Main Methods:

  • Utilized a cat middle cerebral artery occlusion model to simulate focal cerebral ischemia.
  • Employed a rat model of subdural hematoma to study traumatic brain injury.
  • Administered D-CPP-ene at varying doses as pretreatment and post-treatment in occlusion models.

Related Experiment Videos

  • Quantified infarct size and ischemic cortical damage to determine neuroprotection.

    • Main Results:

    • D-CPP-ene pretreatment significantly reduced infarct size in the feline ischemia model by up to 64%.
    • A dose of 1.5 mg/kg did not show significant reduction in infarct size.
    • Post-treatment with D-CPP-ene yielded only slight, non-significant reductions in infarct size.
    • D-CPP-ene pretreatment reduced ischemic damage by 54% in the rat subdural hematoma model.

    Conclusions:

    • D-CPP-ene demonstrates significant neuroprotective efficacy in both ischemic and traumatic brain injury models.
    • Competitive NMDA antagonists like D-CPP-ene may offer clinical benefits for patients with intracranial hematomas.
    • The neuroprotective effects observed in gyrencephalic species are comparable to noncompetitive antagonists.